BLOG

Immune Surveillance and NK Cell Therapy: What Patients in Osaka Should Know

Published 2026.10.13 7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

If you are researching immune-based approaches to cancer, you will often see the phrase immune surveillance. It sounds technical, yet the idea is simple and it helps explain why natural killer (NK) cells attract attention in cancer research. This article explains the concept in plain language and shows how it relates to NK cell therapy offered at Grand Green Osaka Umekita Clinic in Osaka, Japan. It is written for international patients, expatriates living in Japan, and families considering a medical trip.

The short answer is that immune surveillance is the body’s routine work of finding and removing abnormal cells, and NK cell therapy is an option that aims to support that work by returning expanded, activated NK cells that were originally taken from your own blood. It is not a cure, it does not replace standard cancer treatment, and whether it suits you is a decision to make with a physician after an individual consultation.

What immune surveillance means

Even in healthy people, abnormal cells that could develop into cancer are thought to arise from time to time. One reason most people do not develop cancer is thought to be that immune cells, including NK cells, recognize and remove many of these cells before they cause problems. This ongoing monitoring is called immune surveillance.

The concept has been discussed in the scientific literature for decades, and public databases such as PubMed list a large body of research on how tumors interact with the immune system. At the same time, researchers also describe how some cancer cells find ways to avoid detection. For that reason, immune surveillance is best understood as one part of a complex picture rather than a guarantee that the body will always stop cancer on its own.

Where NK cells fit in

NK stands for natural killer. These cells are a type of lymphocyte that circulates in the blood and can detect and attack cancer cells and virus-infected cells. A defining feature is that they can act without waiting for instructions from other immune cells, which is why they are often described as part of the innate, or front-line, immune system.

NK cell activity has been reported to decline with age, with stress, and with the effects of cancer itself. When surveillance weakens, abnormal cells may slip through and multiply more easily. This is the background idea behind NK cell therapy: if the number and activity of NK cells can be increased, the therapy aims to reinforce immune function that has become weaker. It is important to read this as an aim of the treatment and not as a promised outcome.

How NK cell therapy relates to the idea

In NK cell therapy, NK cells obtained from a standard blood draw are activated and expanded outside the body at a licensed cell processing facility. They are then returned to your body by intravenous infusion. Because the cells come from your own body, the therapy is described as autologous, and the risk of rejection is considered low. Temporary reactions such as fever or fatigue may occur, and any treatment can carry risks that your doctor should explain to you.

A blood draw is used to collect the starting cells.
The NK cells are activated and expanded at a specialized facility.
The cells are returned through an IV infusion, without hospital admission.
Your physician reviews how you are feeling and discusses next steps.

The treatment involves a blood draw and an infusion rather than surgery, so many people can continue their daily routines during the course of therapy. However, the number of sessions, the schedule, and the expected course should be confirmed with the clinic, because they depend on your individual situation.

Why it is not a substitute for standard treatment

Immune surveillance is a helpful concept, but it should not lead to the idea that immune cell therapy can stand in for surgery, chemotherapy, or radiation therapy. NK cell therapy is generally considered alongside these standard treatments, and the timing of any combination should be discussed with your treating doctors. The clinic can also coordinate with the medical institution providing your standard care, which is worth raising early in your consultation.

Some patients consider the therapy after standard treatment, with the aim of supporting recurrence prevention or maintaining immune function. Evidence for any individual use varies, and a single study should never be treated as proof. If you read research on PubMed, look at the type of study, the cancer type involved, and whether the findings apply to your own case, and bring your questions to your doctor.

Legal framework and costs in Japan

NK cell therapy at the clinic is a self-pay treatment, which means it is not covered by national health insurance. In Japan, cell-based treatments of this kind are provided under the Act on the Safety of Regenerative Medicine, through a plan that has been submitted to and accepted by the authorities. This framework is intended to support safety management, but it does not remove the need for you to understand the risks, side effects, and costs before deciding.

Fees are listed on the clinic’s treatment page, and the final amount, the number of treatments, and who is eligible are confirmed by a physician during consultation. Please do not assume that any figure you see elsewhere applies to you.

Questions to prepare before you contact the clinic

What is my diagnosis, and what standard treatment am I receiving or planning?
Is NK cell therapy appropriate for my situation, and what are its limits?
What side effects or burdens could I experience, and how are they managed?
How many sessions would be needed, and what does the schedule look like for someone traveling from abroad?
How will the clinic coordinate with my current oncologist?

Bringing recent medical records, test results, and a list of current medications can make the first conversation more useful. Because language can be a barrier in a medical setting, it also helps to know that the clinic provides information pages in multiple languages for international patients.

Summary

Immune surveillance describes how the body routinely looks for and removes abnormal cells, and NK cells are one of the immune components involved. NK cell therapy aims to support this function by returning expanded, activated cells taken from your own blood, but it is a self-pay option provided under Japanese regenerative medicine law, and its suitability, risks, side effects, and costs must be confirmed by a physician. It is not a replacement for standard cancer treatment.

If you are considering a consultation in Osaka, you can review the NK cell therapy page of Grand Green Osaka Umekita Clinic, check the fee and flow information, and contact the clinic through the multilingual channels provided for international patients.

NK Cell Therapy Flow

1Blood drawYour own cells are collected
2Activation and expansionAt a specialized facility
3IV infusionNo hospital admission
4Physician reviewNext steps are discussed

This diagram is a conceptual summary of the article content

Learn more about NK Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to NK Cell Therapy ›